Submitted by jwr@option4.com on Wed, 07/07/2010 - 14:13
In Vivo Purging with Rituximab Before Stem Cell Collection and Maintenance Rituximab After Transplant for Patients with Relapsed Follicular Lymphoma (FL)
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from July 8, 2010) | Subscribe to Dr Love's email alerts | ||
Slides from a presentation at ASCO 2010 and transcribed comments from recent interviews with Stephanie A Gregory, MD (6/18/10) and John P Leonard, MD (6/28/10)
Pettengell R et al. Randomized study of rituximab in patients with relapsed or resistant follicular lymphoma prior to high-dose therapy as in vivo purging and to maintain remission following high-dose therapy. Proc ASCO 2010;Abstract 8005.